TalkMed Group Statistics
Total Valuation
TalkMed Group has a market cap or net worth of SGD 584.17 million. The enterprise value is 499.46 million.
Market Cap | 584.17M |
Enterprise Value | 499.46M |
Important Dates
The last earnings date was Friday, November 8, 2024.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | Aug 14, 2024 |
Share Statistics
TalkMed Group has 1.33 billion shares outstanding. The number of shares has increased by 0.35% in one year.
Current Share Class | n/a |
Shares Outstanding | 1.33B |
Shares Change (YoY) | +0.35% |
Shares Change (QoQ) | +0.50% |
Owned by Insiders (%) | 85.52% |
Owned by Institutions (%) | n/a |
Float | 192.26M |
Valuation Ratios
The trailing PE ratio is 21.17.
PE Ratio | 21.17 |
Forward PE | n/a |
PS Ratio | 7.37 |
PB Ratio | 7.04 |
P/TBV Ratio | n/a |
P/FCF Ratio | 17.33 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.45, with an EV/FCF ratio of 14.82.
EV / Earnings | 17.65 |
EV / Sales | 6.31 |
EV / EBITDA | 14.45 |
EV / EBIT | 15.72 |
EV / FCF | 14.82 |
Financial Position
The company has a current ratio of 3.85, with a Debt / Equity ratio of 0.11.
Current Ratio | 3.85 |
Quick Ratio | 3.79 |
Debt / Equity | 0.11 |
Debt / EBITDA | 0.23 |
Debt / FCF | 0.24 |
Interest Coverage | 143.11 |
Financial Efficiency
Return on equity (ROE) is 33.27% and return on invested capital (ROIC) is 24.30%.
Return on Equity (ROE) | 33.27% |
Return on Assets (ROA) | 19.54% |
Return on Capital (ROIC) | 24.30% |
Revenue Per Employee | 341,017 |
Profits Per Employee | 121,966 |
Employee Count | 232 |
Asset Turnover | 0.75 |
Inventory Turnover | 28.23 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.39% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +15.39% |
50-Day Moving Average | 0.44 |
200-Day Moving Average | 0.40 |
Relative Strength Index (RSI) | 50.25 |
Average Volume (20 Days) | 38,410 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TalkMed Group had revenue of SGD 79.12 million and earned 28.30 million in profits. Earnings per share was 0.02.
Revenue | 79.12M |
Gross Profit | 44.04M |
Operating Income | 32.77M |
Pretax Income | 32.45M |
Net Income | 28.30M |
EBITDA | 33.41M |
EBIT | 32.77M |
Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 85.67 million in cash and 8.19 million in debt, giving a net cash position of 77.48 million or 0.06 per share.
Cash & Cash Equivalents | 85.67M |
Total Debt | 8.19M |
Net Cash | 77.48M |
Net Cash Per Share | 0.06 |
Equity (Book Value) | 75.75M |
Book Value Per Share | 0.06 |
Working Capital | 68.65M |
Cash Flow
In the last 12 months, operating cash flow was 34.32 million and capital expenditures -617,000, giving a free cash flow of 33.70 million.
Operating Cash Flow | 34.32M |
Capital Expenditures | -617,000 |
Free Cash Flow | 33.70M |
FCF Per Share | 0.03 |
Margins
Gross margin is 55.67%, with operating and profit margins of 41.42% and 35.77%.
Gross Margin | 55.67% |
Operating Margin | 41.42% |
Pretax Margin | 41.02% |
Profit Margin | 35.77% |
EBITDA Margin | 42.23% |
EBIT Margin | 41.42% |
FCF Margin | 42.60% |
Dividends & Yields
This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 4.89%.
Dividend Per Share | 0.02 |
Dividend Yield | 4.89% |
Dividend Growth (YoY) | 50.00% |
Years of Dividend Growth | n/a |
Payout Ratio | 103.08% |
Buyback Yield | -0.35% |
Shareholder Yield | 4.54% |
Earnings Yield | 4.72% |
FCF Yield | 5.77% |
Stock Splits
The last stock split was on April 28, 2017. It was a forward split with a ratio of 2.
Last Split Date | Apr 28, 2017 |
Split Type | Forward |
Split Ratio | 2 |
Scores
TalkMed Group has an Altman Z-Score of 14.41.
Altman Z-Score | 14.41 |
Piotroski F-Score | n/a |